Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
112,653
Sort by:
Private Hospital Services Market In India
US$ 800.00
... ), Fortis Healthcare (Fortis), Global Hospitals (Global) and CARE Hospitals (CARE) are some of the leading players in Private Hospital Services market. The Private Hospital Services Market in India is expected to poise a high growth ... to private hospital market in India: India Hospital Services Market Overview Public & Private Hospital Infrastructure Human Resource Investment & Expansion Plans by leading Private Hospital Chain Demand in Tier II Cities: The New Growth Frontier for Private Hospitals
August 2012
85 pages
Analyzing the Medical Disposables Market in the US
US$ 500.00
Demand for disposable medical supplies in the United States is anticipated to rise substantially by 2016. The market has been ... incontinence products. Aruvians Rsearch analyzes the medical disposables market in the US in its research offering Analyzing the Medical Disposables Market in the US. The report ...
August 2012
115 pages
Medicated Skin Care in Iran
US$ 990.00
... of antifungals which are not OTC in Iran. This has resulted in relatively low value growth of consumer health medicated skin care in recent years. The category saw current value growth of 13% in 2011 which... Euromonitor International's Medicated Skin Care in Iran report offers a comprehensive ...
July 2012
23 pages
Medicated Skin Care in the Netherlands
US$ 990.00
... directly exposed to the products, and be better informed. Euromonitor International's Medicated Skin Care in Netherlands report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
July 2012
28 pages
Brazil Healthcare - New Opportunities for Growth
US$ 1,000.00
Brazil is considered as one of the most lucrative healthcare market in Latin America with highest healthcare expenditure. Strong government support and high healthcare services demand are some of the...
July 2012
105 pages
Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module
US$ 4,995.00
Therapy Trends KOL Insight: Rheumatoid Arthritis analyses the current and predicted key issues, clinical advances and late-stage pipeline products in the international and US RA markets. KOL Insight g...
July 2012
245 pages
Global Renal Denervation Market Report: 2012 Edition
US$ 800.00
... ongoing trends in the respective market include Medtronic’s HTN-3 pivotal study, development of novel renal denervation devices, devising of baroreceptor stimulation ... Medical Inc. and Covidien. This RDN Market report attempts to elicit the rapidly evolving market by scrutinizing the novel technologies, product ...
July 2012
42 pages
Medicated Skin Care in Algeria
US$ 990.00
... affluent consumers with regard to hair loss treatments or medicated shampoos. Euromonitor International's Medicated Skin Care in Algeria report offers a comprehensive guide to the size and shape ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
July 2012
22 pages
Medicated Skin Care in Morocco
US$ 990.00
Products in medicated skin care tend to be perceived as unnecessary and luxurious by consumers in Morocco, especially in comparison to other types of products in consumer health, such as those in ... -income consumers consider the price of products in medicated skin care to be too high and they... Euromonitor International's Medicated Skin Care in Morocco report offers a comprehensive guide to the size ...
July 2012
34 pages
Medicated Skin Care in Serbia
US$ 990.00
... of medicated skin care products in 2011. At the same time, the variety of available products saw a constant increase, as well as their distribution, which brought medicated skin care products ... was 4%, which is an indicator of growth in volume sales of these... Euromonitor International's Medicated Skin Care in Serbia report offers a comprehensive guide to the size and shape of the ...
July 2012
28 pages
REGENERON - Riding High on the Back of Eylea...
US$ 90.00
... ’s ability to buffer the setbacks in the pipeline. In today’s 2Q12 earnings, Regeneron (REGN) reported sales of $194m way above street expectations (our ...
July 2012
4 pages
Medicated Skin Care in Austria
US$ 990.00
... of medicated skin care was influenced by rising health awareness among Austrian consumers as well as their positive attitude towards beauty and personal appearance. Consumers in Austria ... consumers as well. As a result consumers are increasingly demanding medicated skin care products... Euromonitor International's Medicated Skin Care in Austria report offers a comprehensive guide to the size and shape ...
July 2012
29 pages
VIVUS – Qsymia’s Launch and Ex-US Partnership = Growth Drivers
US$ 140.00
... launch by 4Q12 ahead of rival drug, Arena/Eisai's Belviq (loracaserin, 5-HT2C receptor agonist) should give Vivus (VVUS) the first mover advantage, as Qsymia ... , please read our report released on July 19, 2012 on VVUS, titled “Qsymia’s Launch and Ex-US Partnership = Growth Drivers
July 2012
3 pages
Medicated Skin Care in Nigeria
US$ 990.00
... , consumers are spending more on skin care products, which they had hitherto considered non-essential. Euromonitor International's Medicated Skin Care in Nigeria report offers a comprehensive guide ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
July 2012
25 pages
Medicated Skin Care in Germany
US$ 990.00
Medicated skin care enjoyed the seventh successive year of positive value growth in Germany (in current terms) and saw sales grow by almost 2% to €445 million in ... advice), while for others there are time... Euromonitor International's Medicated Skin Care in Germany report offers a comprehensive guide to the size and shape of the ...
July 2012
43 pages
GLOBAL PHARMA SCREEN FOR TOP PICK
US$ 500.00
We recommend MRK and Roche as our Top pick from Global pharma space. NVS as well is interesting, trading at defensive valuations, but except ... they do one could see up to 30-40% upside from current levels. Our screening criteria is based on: Expected News flow from Pipeline and Potential ...
July 2012
21 pages
Shionogi - Dolutegravir Can Bring ‘Good Times’ Back to Shionogi!
US$ 140.00
... encouraging and similar outcome from four late stage studies can bring Dolutegravir in forefront of anti-HIV therapy – this is the first ... changing in anti-HIV regime, we expect dolutegravir has potential to cross $2.5b. In this report we have analyzed dolutegravir opportunity in mono-thx and in combination ...
July 2012
5 pages
Remote and Wireless Patient Monitoring Markets
US$ 3,995.00
... record (EMR), and some come with full-service outsourcing. Patient monitoring parameters range from basic vital signs toelectrocardiograms (ECGs). ... , thermometers, weight scales and other functions. This Kalorama Information report, Remote & Wireless Patient Monitoring Markets covers three product areas: ...
July 2012
200 pages
China Computed Radiography (CR) Market Assessment and Outlook 2012-2015
US$ 2,000.00
... market and provides an in-depth analysis of the CR market in China. The report outlines China’s Computed Radiography (CR) market, including user survey results and ... examines hospital purchasing plans and procedures, total sales of CRs, and CR market shares. This study draws from first-hand interviews and ...
July 2012
57 pages
Mitsubishi Tanabe - Collategene US Marketing Rights – A Bet to Get Trump Card for US!
US$ 90.00
Mitsubishi Tanabe (MT) announcement to acquire US marketing rights of Collategene (preparing PhIII, PAD, Anges) ... (MTP) - but are subject to PhIII outcome of Collategene. A solid data in PhIII will prompt MT to ... analyze that the concept and approach of Collategene carries an attractive ‘high-risk-high-reward ...
July 2012
3 pages
Medicated Skin Care in Italy
US$ 990.00
... STRONG GROWTH RATES IN MEDICATED SKIN CARE CLEARLY WITNESSES HOW ITALIANS ARE BECOMING AWARE OF THE RISK RELATED TO A BAD CARE OF THEIR SKIN. MEDIA’S CAMPAIGNS AIMED ... PRODUCTS FOR EXAMPLE, HAVE BEEN VERY EFFECTIVE. Euromonitor International's Medicated Skin Care in Italy report offers a comprehensive guide to the size and shape of the ...
July 2012
45 pages
Pre-Filled Syringes: World Market Prospects 2012-2022
US$ 2,635.00
... 90 tables, 54 charts and six research interviews. Nine ways Pre-Filled Syringes: World Market Prospects 2012-2022 helps you In particular, our ... to 2022 Find projected revenues of 14 leading therapeutic products to 2022 See market forecasting to 2022 for the US, Japan, 5 leading EU countries, China and ...
July 2012
217 pages
Medicated Skin Care in Hungary
US$ 990.00
... TREATMENTS. COSMECEUTICALS RECOGNISED THE NEED FOR MEDICATED SKIN CARE PRODUCTS AND LAUNCHED WHOLE PRODUCT... Euromonitor International's Medicated Skin Care in Hungary report offers a comprehensive guide to the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
July 2012
37 pages
U.S. Market for Soft Tissue Repair
US$ 7,495.00
... , residual demand boosted procedure volumes. Within the soft tissue and sports medicine market, companies such as Arthrex, ArthroCare, ConMed Linvatec, ... report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, ...
July 2012
262 pages
International Physician Survey: Stents by Brand, Length, Diameter, Type and Coating
US$ 6,995.00
... and treatment and endovascular imaging technologies. The Global Physician Survey on Stents, Stent-Grafts and Endovascular Imaging includes: Europe Asia- ... Most Important Benefit When Using Bifurcated Stents Preferred Bifurcated Stent Alternative Bioabsorbable Stents and Their Use Most Important Benefit ...
July 2012
114 pages
U.S. End-User Dental Materials Survey Report
US$ 6,995.00
... currently available across the United States. The topics covered include: Injectable and Topical Anesthetic Use Dental Material Brand Preferences Purchasing ... determined through this report, including those for anesthetics, etches, bonds, dental cements and other products. For each product, the reasons ...
July 2012
96 pages
Asia Pacific Vascular Access
US$ 8,995.00
The Asia-Pacific vascular access device market reached nearly $360 million in 2011.The vascular access device market is growing because of the increasing size and age of the patient pool. In 2011, the total population of the countries covered by this report was approximately ...
July 2012
266 pages
Competitor Analysis: B7 – CD28/CTLA-4 Pathway
US$ 370.00
... /CTLA-4 signaling family to treat autoimmune diseases or cancer. In addition, the report lists company-specific R&D pipelines of projects in the B7 – CD28/CTLA-4 pathway. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound ...
July 2012
35 pages
Sampling: A Key Business Driver in a Multi-channel Environment
US$ 595.00
... future of sampling is undoubtedly digital, but what are the best ways for brands to make this critical transition? Report Overview Sampling: A key business driver in a multi ... predictions for the future of product sampling. Sampling: A key business driver in a multi-channel environment is designed to help sales, marketing, and sampling logistics leaders learn best practices ...
June 2012
53 pages
Recreational, Outdoor, and Fitness GPS Solutions: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Recreational, Outdoor, and Fitness GPS Solutions in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are ...
June 2012
486 pages
Eisai, Belviq Approval – Implications on Eisai’s Bottom Line is Weak!
US$ 90.00
We continue with our Underperform rating on Eisai following approval of Belviq (lorcaserin, 5 HT 2C agonist, partnered with Arena) in the US. Despite ... (Qnexa has PDUFA date on 26th July 2012; we are expecting approval). Belviq administration is to be discontinued if 5% weight loss is not achieved within 12 ...
June 2012
3 pages
